Literature DB >> 25395615

Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Frank M Davis1, Debra L Rateri1, Anju Balakrishnan1, Deborah A Howatt1, Dudley K Strickland1, Selen C Muratoglu1, Christopher M Haggerty1, Brandon K Fornwalt1, Lisa A Cassis1, Alan Daugherty2.   

Abstract

OBJECTIVE: Low-density lipoprotein receptor-related protein 1 (LRP1), a multifunctional protein involved in endocytosis and cell signaling pathways, leads to several vascular pathologies when deleted in vascular smooth muscle cells (SMCs). The purpose of this study was to determine whether LRP1 deletion in SMCs influenced angiotensin II-induced arterial pathologies. APPROACH AND
RESULTS: LRP1 protein abundance was equivalent in selected arterial regions, but SMC-specific LRP1 depletion had no effect on abdominal and ascending aortic diameters in young mice. To determine the effects of LRP1 deficiency on angiotensin II vascular responses, SMC-specific LRP1 (smLRP1(+/+)) and smLRP1-deficient (smLRP1(-/-)) mice were infused with saline, angiotensin II, or norepinephrine. Several smLRP(-/-) mice died of superior mesenteric arterial (SMA) rupture during angiotensin II infusion. In surviving mice, angiotensin II profoundly augmented SMA dilation in smLRP1(-/-) mice. SMA dilation was blood pressure dependent as demonstrated by a similar response during norepinephrine infusion. SMA dilation was also associated with profound macrophage accumulation, but minimal elastin fragmentation. Angiotensin II infusion led to no significant differences in abdominal aorta diameters between smLRP1(+/+) and smLRP1(-/-) mice. In contrast, ascending aortic dilation was exacerbated markedly in angiotensin II-infused smLRP1(-/-) mice, but norepinephrine had no significant effect on either aortic region. Ascending aortas of smLRP1(-/-) mice infused with angiotensin II had minimal macrophage accumulation but significantly increased elastin fragmentation and mRNA abundance of several LRP1 ligands including MMP-2 (matrix metalloproteinase-2) and uPA (urokinase plasminogen activator).
CONCLUSIONS: smLRP1 deficiency had no effect on angiotensin II-induced abdominal aortic aneurysm formation. Conversely, angiotensin II infusion in smLRP1(-/-) mice exacerbated SMA and ascending aorta dilation. Dilation in these 2 regions had differential association with blood pressure and divergent pathological characteristics.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  LRP1 protein, mouse; angiotensin II; aortic aneurysm

Mesh:

Substances:

Year:  2014        PMID: 25395615      PMCID: PMC4332619          DOI: 10.1161/ATVBAHA.114.304683

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  39 in total

1.  Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.

Authors:  L Hu; L S M Boesten; P May; J Herz; N Bovenschen; M V Huisman; J F P Berbée; L M Havekes; B J M van Vlijmen; J T Tamsma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-12       Impact factor: 8.311

2.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

3.  Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse.

Authors:  Cheryl D Overton; Patricia G Yancey; Amy S Major; MacRae F Linton; Sergio Fazio
Journal:  Circ Res       Date:  2007-02-15       Impact factor: 17.367

4.  Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

Authors:  Lisa A Cassis; Debra L Rateri; Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

5.  Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.

Authors:  Judith Sendra; Vicenta Llorente-Cortés; Paula Costales; Claudia Huesca-Gómez; Lina Badimon
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

6.  Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients.

Authors:  Silvia Galora; Claudia Saracini; Giovanni Pratesi; Elena Sticchi; Raffaele Pulli; Carlo Pratesi; Rosanna Abbate; Betti Giusti
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

7.  Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.

Authors:  Victoria L King; Darshini B Trivedi; Jonathan M Gitlin; Charles D Loftin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-02       Impact factor: 8.311

8.  Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Authors:  D E Vaughan; S A Lazos; K Tong
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

Authors:  Lisa A Cassis; Manisha Gupte; Sarah Thayer; Xuan Zhang; Richard Charnigo; Deborah A Howatt; Debra L Rateri; Alan Daugherty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

10.  LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation.

Authors:  Li Zhou; Yoshiharu Takayama; Philippe Boucher; Michelle D Tallquist; Joachim Herz
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more
  29 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

2.  NLRP3 (Nucleotide Oligomerization Domain-Like Receptor Family, Pyrin Domain Containing 3)-Caspase-1 Inflammasome Degrades Contractile Proteins: Implications for Aortic Biomechanical Dysfunction and Aneurysm and Dissection Formation.

Authors:  Darrell Wu; Pingping Ren; Yanqiu Zheng; Lin Zhang; Gaiping Xu; Wanmu Xie; Eric E Lloyd; Sui Zhang; Qianzi Zhang; John A Curci; Joseph S Coselli; Dianna M Milewicz; Ying H Shen; Scott A LeMaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

Review 3.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

4.  A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy.

Authors:  Nicholas B Cavanaugh; Lan Qian; Nicole M Westergaard; William J Kutschke; Ella J Born; Joseph W Turek
Journal:  Ann Thorac Surg       Date:  2017-03-27       Impact factor: 4.330

Review 5.  Aortic Aneurysms and Dissections Series.

Authors:  Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-26       Impact factor: 8.311

Review 6.  Aortic Aneurysms.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06       Impact factor: 8.311

Review 7.  Updates of Recent Aortic Aneurysm Research.

Authors:  Frank M Davis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

Review 8.  Abdominal aortic aneurysm: novel mechanisms and therapies.

Authors:  Frank M Davis; Debra L Rateri; Alan Daugherty
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

Review 9.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

10.  LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Regulates Smooth Muscle Contractility by Modulating Ca2+ Signaling and Expression of Cytoskeleton-Related Proteins.

Authors:  Dianaly T Au; Zhekang Ying; Erick O Hernández-Ochoa; William E Fondrie; Brian Hampton; Mary Migliorini; Rebeca Galisteo; Martin F Schneider; Alan Daugherty; Debra L Rateri; Dudley K Strickland; Selen C Muratoglu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.